The effects of EPA, DHA, and aspirin ingestion on plasma lysophospholipids and autotaxin.

[1]  Zhenwen Zhao,et al.  Measurement of endogenous lysophosphatidic acid by ESI-MS/MS in plasma samples requires pre-separation of lysophosphatidylcholine. , 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[2]  T. Decsi,et al.  Methods of assessment of n-3 long-chain polyunsaturated fatty acid status in humans: a systematic review. , 2009, The American journal of clinical nutrition.

[3]  V. Natarajan,et al.  Lipid phosphate phosphohydrolase type 1 (LPP1) degrades extracellular lysophosphatidic acid in vivo. , 2009, The Biochemical journal.

[4]  Yutong Zhao,et al.  Lysophosphatidic acid signaling in airway epithelium: role in airway inflammation and remodeling. , 2009, Cellular signalling.

[5]  M. Kurokawa,et al.  Serum autotaxin measurement in haematological malignancies: a promising marker for follicular lymphoma , 2008, British journal of haematology.

[6]  J. Chun,et al.  Lysophosphatidic Acid Receptors 1 and 2 Play Roles in Regulation of Vascular Injury Responses but Not Blood Pressure , 2008, Circulation research.

[7]  J. Aoki,et al.  Two pathways for lysophosphatidic acid production. , 2008, Biochimica et biophysica acta.

[8]  G. Prestwich,et al.  Phosphatase-resistant analogues of lysophosphatidic acid: agonists promote healing, antagonists and autotaxin inhibitors treat cancer. , 2008, Biochimica et biophysica acta.

[9]  J. Schwab,et al.  Resolvin E1, an EPA-derived mediator in whole blood, selectively counterregulates leukocytes and platelets. , 2008, Blood.

[10]  A. Morris,et al.  Therapeutic potential of autotaxin/lysophospholipase d inhibitors. , 2008, Current drug targets.

[11]  Y. Yatomi,et al.  Measurement of plasma lysophosphatidic acid concentration in healthy subjects: strong correlation with lysophospholipase D activity , 2008, Annals of clinical biochemistry.

[12]  Zhan-cai Yu,et al.  Influence of acetylsalicylate on plasma lysophosphatidic acid level in patients with ischemic cerebral vascular diseases , 2008, Neurological research.

[13]  K. Harris,et al.  Effects of omega-3 acid ethyl esters and aspirin, alone and in combination, on platelet function in healthy subjects , 2008, Thrombosis and Haemostasis.

[14]  B. Lacour,et al.  Dietary n-3 polyunsaturated fatty acids and endothelium dysfunction induced by lysophosphatidylcholine in Syrian hamster aorta. , 2008, Metabolism: clinical and experimental.

[15]  Li Li,et al.  Plasma lysophosphatidylcholine levels: potential biomarkers for colorectal cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  W. Harris.  Expert opinion: omega-3 fatty acids and bleeding-cause for concern? , 2007, The American journal of cardiology.

[17]  D. Mozaffarian,et al.  Plasma Phospholipid Trans Fatty Acids, Fatal Ischemic Heart Disease, and Sudden Cardiac Death in Older Adults: The Cardiovascular Health Study , 2006, Circulation.

[18]  J. Wylie-Rosett,et al.  Diet and Lifestyle Recommendations Revision 2006: A Scientific Statement From the American Heart Association Nutrition Committee , 2006, Circulation.

[19]  C. Mummery,et al.  Autotaxin, a Secreted Lysophospholipase D, Is Essential for Blood Vessel Formation during Development , 2006, Molecular and Cellular Biology.

[20]  R. Hauer,et al.  Effect of fish oil on ventricular tachyarrhythmia and death in patients with implantable cardioverter defibrillators: the Study on Omega-3 Fatty Acids and Ventricular Arrhythmia (SOFA) randomized trial. , 2006, JAMA.

[21]  G. Prestwich,et al.  Fluorogenic phospholipid substrate to detect lysophospholipase D/autotaxin activity. , 2006, Organic letters.

[22]  Colin Baigent,et al.  Low-dose aspirin for the prevention of atherothrombosis. , 2005, The New England journal of medicine.

[23]  P. Ridker,et al.  Aspirin Has A Gender-Dependent Impact on Antiinflammatory 15-Epi-Lipoxin A4 Formation: A Randomized Human Trial , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[24]  M. Josephson,et al.  Prevention of Fatal Arrhythmias in High-Risk Subjects by Fish Oil n-3 Fatty Acid Intake , 2005, Circulation.

[25]  Joshua T. Cohen,et al.  A quantitative risk-benefit analysis of changes in population fish consumption. , 2005, American journal of preventive medicine.

[26]  Chiung-Nien Chen,et al.  Lysophospholipids enhance matrix metalloproteinase-2 expression in human endothelial cells. , 2005, Endocrinology.

[27]  S. Chugh,et al.  Fish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrillators: a randomized controlled trial. , 2005, JAMA.

[28]  K. Tracey,et al.  Suppression of HMGB1 release by stearoyl lysophosphatidylcholine:an additional mechanism for its therapeutic effects in experimental sepsis. , 2005, Journal of lipid research.

[29]  J. Aoki.  Mechanisms of lysophosphatidic acid production. , 2004, Seminars in cell & developmental biology.

[30]  C. Porter,et al.  Omega-3 Fatty Acids in Cardiac Biopsies From Heart Transplantation Patients: Correlation With Erythrocytes and Response to Supplementation , 2004, Circulation.

[31]  W. Harris,et al.  The Omega-3 Index: a new risk factor for death from coronary heart disease? , 2004, Preventive medicine.

[32]  H. Suh,et al.  Therapeutic effects of lysophosphatidylcholine in experimental sepsis , 2004, Nature Medicine.

[33]  D. Kereiakes.  Adjunctive Pharmacotherapy before Percutaneous Coronary Intervention in Non-ST-Elevation Acute Coronary Syndromes: The Role of Modulating Inflammation , 2003, Circulation.

[34]  Y. Ohkawa,et al.  Vascular Remodeling Induced by Naturally Occurring Unsaturated Lysophosphatidic Acid In Vivo , 2003, Circulation.

[35]  Hohyun Kim,et al.  Quantitative analysis of acyl-lysophosphatidic acid in plasma using negative ionization tandem mass spectrometry. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[36]  Lawrence J Appel,et al.  Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[37]  G. Mills,et al.  Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production , 2002, The Journal of cell biology.

[38]  A. Mattioli,et al.  Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients , 2002, BMJ : British Medical Journal.

[39]  R. Peto,et al.  Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients , 2002, BMJ : British Medical Journal.

[40]  M. Reilly,et al.  Cyclooxygenase inhibitors and the antiplatelet effects of aspirin. , 2001, The New England journal of medicine.

[41]  M. Lopez-Sabater,et al.  Comparison of two direct methods for the determination of fatty acids in human milk , 2001 .

[42]  Y. Ohkawa,et al.  Phenotypic Modulation of Vascular Smooth Muscle Cells Induced by Unsaturated Lysophosphatidic Acids , 2001, Circulation research.

[43]  J. Lecerf,et al.  Lysophosphatidylcholine as a preferred carrier form of docosahexaenoic acid to the brain , 2001, Journal of Molecular Neuroscience.

[44]  R. London,et al.  Aspirin acetylation of betaLys-82 of human hemoglobin. NMR study of acetylated hemoglobin Tsurumai. , 2000, Biochemical pharmacology.

[45]  H. Krutzsch,et al.  Identification, purification, and partial sequence analysis of autotaxin, a novel motility-stimulating protein. , 1992, The Journal of biological chemistry.

[46]  P. K. Smith,et al.  Inhibition of glycation of albumin and hemoglobin by acetylation in vitro and in vivo. , 1986, The Journal of laboratory and clinical medicine.

[47]  Tokumura Akira,et al.  Involvement of lysophospholipase D in the production of lysophosphatidic acid in rat plasma. , 1986 .

[48]  G. Schmitz,et al.  Metabolism and atherogenic disease association of lysophosphatidylcholine. , 2010, Atherosclerosis.